BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28728274)

  • 21. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
    Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation.
    Yomota M; Yanagawa N; Sakai F; Yamada Y; Sekiya N; Ohashi K; Okamura T
    Medicine (Baltimore); 2019 Jan; 98(1):e13951. PubMed ID: 30608429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
    Yoshihara S; Yanik G; Cooke KR; Mineishi S
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):749-59. PubMed ID: 17580252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
    Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
    Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of high-dose steroids for bronchiolitis obliterans syndrome post pediatric hematopoietic stem cell transplantation.
    Even-Or E; Ghandourah H; Ali M; Krueger J; Sweezey NB; Schechter T
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29417689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
    Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.
    Soubani AO; Kingah P; Alshabani K; Muma G; Haq A
    Clin Transplant; 2014 Jul; 28(7):776-82. PubMed ID: 24754643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?
    Okumura H; Ohtake S; Ontachi Y; Ozaki J; Shimadoi S; Waseda Y; Kondo Y; Yamazaki H; Takami A; Yasui M; Date H; Nakao S
    Int J Hematol; 2007 Nov; 86(4):369-73. PubMed ID: 18055347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation.
    Barisione G; Bacigalupo A; Crimi E; Brusasco V
    Chest; 2011 Mar; 139(3):633-639. PubMed ID: 20724742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J
    Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Barotrauma Following Nasal High-Flow Therapy in a Patient with Bronchiolitis Obliterans Syndrome.
    Ito T; Suzuki T; Maeda M; Iwamoto S; Hirayama M; Yamada Y; Azuma E
    Am J Case Rep; 2019 Nov; 20():1619-1622. PubMed ID: 31680117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Inamoto Y; Martin PJ; Onstad LE; Cheng GS; Williams KM; Pusic I; Ho VT; Arora M; Pidala J; Flowers MED; Gooley TA; Lawler RL; Hansen JA; Lee SJ
    Transplant Cell Ther; 2021 Sep; 27(9):759.e1-759.e8. PubMed ID: 34126278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical analysis of lung transplantation in eight patients with obstructive bronchiolitis syndrome after hematopoietic stem cell transplantation].
    Wang LL; Wang HY; Shen YF; Lu MZ; Chen JY; Wu B
    Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):977-980. PubMed ID: 29224324
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
    Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
    Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
    Au BK; Au MA; Chien JW
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
    Bacigalupo A; Chien J; Barisione G; Pavletic S
    Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study.
    Lam DC; Lam B; Wong MK; Lu C; Au WY; Tse EW; Leung AY; Kwong YL; Liang RH; Lam WK; Ip MS; Lie AK
    Bone Marrow Transplant; 2011 Dec; 46(12):1551-6. PubMed ID: 21317934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.